Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals-Reference-Cited by-同舟云学术

Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals

Published:1999-12 Issue:6 Volume:13 Page:867-877
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Coquette A.,Berna N.,Vandenbosch A.,Rosdy M.,Poumay Y.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference39 articles.

1. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis;Anttila;Journal of Investigative Dermatology,1992

2. 1-chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase-Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity;Arner;Journal of Biological Chemistry,1995

3. Role of keratinocytes in allergic contact dermatitis;Barker;Contact Dermatitis,1992

4. Keratinocytes as initiators of inflammation;Barker;Lancet,1991

5. The living skin equivalent: its manufacture, its organotypic properties and its responses to irritants;Bell;Toxicology in Vitro,1991

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Engineered Skin Tissue for Cosmetic Component and Toxicology Detection;Cell Transplantation;2024-01

2. Assessment of antibacterial properties and skin irritation potential of anodized aluminum impregnated with various quaternary ammonium;Biomaterials Advances;2023-07

3. Bioprinted and manual human epidermis production: A compared performance for skin irritation tests;Bioprinting;2023-02

4. Human Epidermal Keratinocytes in Culture: A Story of Multiple Recipes for a Single Cell Type;Skin Pharmacology and Physiology;2023

5. Skin Disease Models In Vitro and Inflammatory Mechanisms: Predictability for Drug Development;Organotypic Models in Drug Development;2021